News

Genomtec S.A. will conduct additional comparative study of its test detecting SARS-CoV-2 directly from saliva sample utilizing the Direct-RT-LAMP ...

Genomtec S.A., listed on the NewConnect market at Warsaw Stock Exchange, a company developing medical technology applicable in segment of ...

Company has been granted a patent protection from the Patent Office of the Republic of Poland for a set of primers amplifying Borrelia ...

Company signed an agreement with the Lower Silesian Medical Center DOLMED S.A. – the leader of multidisciplinary healthcare provision in Wroclaw ...

The patent application concerns the proprietary set of primers, the diagnostic method and the reaction mixture composition for genetic diagnosis ...

Company has recently confirmed diagnostic positive performance of its most advanced product, Genomtec® SARS-CoV-2 EvaGreen® RT-LAMP CE-IVD Duo ...